13 Jan 2025·Department of Health and Social Care·Answered
AskedWhat the average waiting time was for an autism diagnosis in Kent in (a) 2025 and (b) 2020; and what steps his Department is taking to reduce waiting times for receiving an autism diagnosis.
ReplyThe information is not held centrally in the format requested, but may be held by individual providers or integrated care boards (ICBs). Some relevant information is available on autism assessment waiting times for the NHS Kent and Medway ICB.In the NHS Kent and Medway ICB, the Autism Waiting Time Statistics published by NHS England show that there were a total of 8,695 patients with an open suspected autism referral in September 2024, the latest available data, and a total of 3,015 patients with an open suspected autism referral in September 2020. The median waiting time of all patients in this ICB with an open suspected autism referral, where their first care contact was in the quarter, was 483 days in September 2024, and 139 days in September 2020.Data on children and young people in this dataset is expected to be an underestimate and caution should be used when interpreting these statistics since they are experimental rather than official statistics.It is the responsibility of ICBs to make available appropriate provision to meet the health and care needs of their local population, including autism assessments and diagnosis, in line with relevant National Institute for Health and Care Excellence guidelines.
13 Jan 2025·Department of Health and Social Care·Answered
AskedIf he will make an assessment of the potential merits of issuing guidance to hospitals on using withheld numbers to contact patients about appointments.
ReplyNational Health Services may sometimes choose to use withheld numbers when contacting patients, including to protect patient privacy and confidentiality, but we appreciate the frustration that patients can feel when they are unable to contact clinical staff, especially following a call from a withheld number, and recognise the importance of patients being able to establish channels of two-way communication.The Elective Reform Plan, launched as part of the Government’s Plan for Change, sets out the reform and productivity efforts needed to ensure patients are seen on time, but also to improve their experience of care, which includes enhancing and improving two-way communication between patients and NHS services, whether through digital options such as an enhanced NHS App or non-digital routes.
13 Jan 2025·Home Office·Answered
AskedWhat her planned timetable is for the implementation of the Protection from Sex-based Harassment in Public Act 2023.
ReplyThe Government is committed to halving levels of violence against women and girls in a decade. An important part of this ambition is tackling public sexual harassment which often leaves people, disproportionately women, feeling very unsafe. The Protection from Sex-Based Harassment in Public Act 2023 is intended to make this type of harassment a specific offence.As with any new criminal justice legislation, an implementation period is necessary to ensure all processes, systems and guidance are updated - including drawing up statutory guidance. We will confirm next steps on implementation of the Act at the earliest opportunity.
13 Jan 2025·Department of Health and Social Care·Answered
AskedIf he will make an assessment of the potential merits of ensuring that private ambulance service personnel on NHS contracts receive (a) recognition and (b) honours.
ReplyUnder the honours system of the United Kingdom, anyone can receive an award, and anyone can nominate someone if they demonstrate the exceptional contribution the person has made.Recognition for those working in the private sector is primarily a matter for their employers.
13 Jan 2025·Treasury·Answered
AskedWith reference to the planned reforms to agricultural property relief, what steps her Department will take to support farmers who have lost their exemption because their (a) spouse or (b) civil partner has died.
ReplyThe Government published information about the reforms to agricultural property relief at www.gov.uk/government/publications/agricultural-property-relief-and-business-property-relief-reforms. The reforms mean that individuals can access 100% relief for the first £1 million of combined business and agricultural assets, and 50% relief thereafter - meaning an effective tax rate of up to 20% – regardless of their relationship status. Any liability can also be paid over 10 years interest free – a benefit that is not seen anywhere else in the inheritance tax system. It is expected that up to around 2,000 estates will be affected by the changes to APR and BPR in 2026-27, with around half of those being claims that involve AIM shares. Almost three-quarters of estates claiming agricultural property relief (or those claiming agricultural property relief and business property relief together) are expected to be unaffected by these reforms.
13 Jan 2025·Home Office·Answered
AskedIf she will make an assessment of the potential merits of imposing civil rather than criminal penalties on people found in possession of drugs for personal use.
ReplyThere are no plans to decriminalise illicit drug use. The law allows for the prosecution of those who commit offences, including drug possession and supply. The police have a range of alternative options within the out of court resolution framework (such as community resolutions, cautions and deferred prosecutions) to direct individuals into meaningful interventions to address their drug use, and divert them away from the criminal justice system.
13 Jan 2025·Home Office·Answered
AskedIf she will make an assessment of the potential merits of moving responsibility for drugs policy to the Department of Health and Social Care.
ReplyResponsibility for drug policy is shared across a number of departments and both the Home Office and the Department for Health and Social Care have important roles to play in setting policy to tackle drug use and to reduce drug-related crime and drug health harms. The Home Office is the lead department for the Misuse of Drugs Act 1971 and associated drug legislation, working with other departments as appropriate where changes in the law are required. We have no plans to change this.Illicit drug use affects the whole of society, and this Government is taking a collective response which will help our key missions to deliver safer streets, improve health outcomes and contribute to opportunities and growth through reducing crime and saving lives.
13 Jan 2025·Department for Work and Pensions·Answered
AskedWhat assessment she has made of the effectiveness of the Rodenticide Stewardship Scheme in reducing wildlife exposure to rat poisons; and if she will make an assessment of the potential merits of taking further steps to combat criminal use of rat poisons to kill birds of prey.
ReplyThe Rodenticides Stewardship Scheme was developed by The Campaign for Responsible Rodenticide Use UK to promote responsible use and is overseen by the Government Oversight Group for Rodenticide Stewardship (GOG), chaired by the Health and Safety Executive (HSE). The GOG is conducting a review of rodenticide stewardship, under which it will consider all appropriate evidence. The detailed work of this review is expected to be completed in 2025. Wildlife crime is a matter for Department for Environment, Food and Rural Affairs (Defra), the Welsh and Scottish Governments, and the Police. Bird of prey crime is identified by Defra as a national wildlife crime priority, and significant sanctions are available against proven perpetrators of the crime, including an unlimited fine and/or a six-month custodial sentence. HSE may also take action, where appropriate, in its role as a workplace health and safety regulator.
13 Jan 2025·Department for Education·Answered
AskedIf she will make an assessment of the potential merits of (a) fast-tracking higher-level teaching assistants to become teachers and (b) introducing teaching apprenticeships.
ReplyTeaching assistants (TAs) play a vital role in children’s education. They are crucial to ensuring we give children the best possible life chances. The ‘use of teaching assistants in schools’ departmental survey from 2023 found that 23% of TAs with a higher level teaching assistant (HLTA) qualification were ‘extremely’ or ‘very’ interested in undertaking training to become a teacher. TAs who are interested in gaining qualified teacher status (QTS) can do so through a range of existing routes. TAs can gain QTS through both fee-funded and salaried Initial Teacher Training (ITT). Salaried routes allow TAs to continue to earn an income and may provide the opportunity to remain employed by their current school. Salaried ITT includes School Direct (salaried) routes and the Postgraduate Teacher Apprenticeship (PGTA) for TAs with an undergraduate degree, and the Teacher Degree Apprenticeship (TDA) for those without an undergraduate degree. Teaching apprenticeships already exist and expand opportunities for people to become excellent teachers and allow successful candidates to earn and learn whilst obtaining QTS. In spring 2024, the Institute for Apprenticeships and Technical Education approved the new TDA standard. Candidate recruitment to the TDA began in autumn 2024 and training will commence in autumn 2025. The PGTA will continue to be available in the 2025/26 academic year. Some TAs with an undergraduate degree and significant teaching experience may be eligible for the assessment only route to QTS. This route allows experienced teachers to gain QTS without undertaking additional training. To be eligible, currently, candidates must be able to demonstrate that they meet the Teachers' Standards without further training and have evidence of teaching experience (i) in at least two schools (ii) for at least two years.
13 Jan 2025·Foreign, Commonwealth and Development Office·Answered
AskedCommonwealth and Development Affairs, if he will make an assessment of the potential impact of continuation of the conflict in Sudan on the number of Sudanese refugees seeking asylum in the United Kingdom.
ReplyOver 3.6 million people have fled Sudan since the current conflict began in April 2023; many more (8.8 million people) have been internally displaced. Those fleeing Sudan in need of international protection should claim asylum in the first safe country they reach - that is the fastest route to safety. The UK continues to use all diplomatic means possible to bring the warring parties to the table to end this conflict - the surest way to ensure people can stay safely in Sudan. The UK continues to provide significant support to those fleeing Sudan, most recently with the Foreign Secretary announcing a major aid increase of £113 million on 17 November 2024 to support people affected by the conflict, including in neighbouring countries, such as Chad and South Sudan. The Minister for International Development and HRH The Duchess of Edinburgh witnessed the impact of the crisis on people in neighbouring countries first-hand during their respective visits to South Sudan and Chad last year.
13 Jan 2025·Department of Health and Social Care·Answered
AskedIf he will take steps to ensure that NHS patients who consent to have their data shared with UK medical institutions for research and development will not have their data shared overseas.
ReplyResearch studies in which patients choose to share their data must adhere to strict legal and ethical standards, including compliance with the United Kingdom’s General Data Protection Regulation (UK GDPR) and the common law duty of confidentiality. As part of this, participants must be fully informed about how their data will be used, including with whom it might be shared, so they can make an informed decision about their participation.The National Health Service and major UK research institutions are increasingly adopting secure data environments for data access, with researchers accessing data through secure online portals rather than it being directly shared with them. Each NHS and research organisation has its own processes when sharing data that ensure that they comply with legal requirements. Consent materials would explain the circumstances where data may be made available outside of the UK.NHS England, for example, enters into formal data sharing agreements where it is sharing information with researchers, which specifies the geographical area within which data processing is permitted. Where data processing occurs outside the UK, additional conditions must be fulfilled to ensure researchers put in place adequate organisational and technical controls, and comply with their legal responsibilities in relation to overseas transfers that are required under UK GDPR.NHS England undertakes routine audits of data sharing agreements to ensure that high standards are consistently maintained.
3 Jan 2025·Department for Transport·Answered
AskedWhat the penalties are when the LAeq noise contour threshold at Stansted Airport is exceeded; and who enforces those noise restrictions.
ReplyStansted Airport’s noise contour limit has been set through a local planning agreement. Enforcement of local planning conditions at Stansted Airport is a matter for the local authority, Uttlesford District Council.
19 Dec 2024·Department of Health and Social Care·Answered
AskedWhat steps his Department is taking to ensure that people with long covid are adequately supported.
ReplyI know firsthand how complex and debilitating long COVID can be.Since 2020, specialist long COVID services have been made available in England, and NHS England is now completing a stocktake of these services.This will provide an accurate national picture, identify key challenges and make strategic recommendations for future service improvement, development and assurance.We have also invested over £57 million in long COVID research.
17 Dec 2024·Department of Health and Social Care·Answered
AskedIf he will make an assessment of the potential merits of establishing a British supplier of Creon.
ReplyThe Department has been working with suppliers to address current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy (PERT) used by patients with conditions such as cystic fibrosis and certain cancers, including pancreatic cancer. The supply issues with Creon are impacting countries throughout Europe and have been caused by the limited availability of raw ingredients and manufacturing capacity constraints to produce volumes needed to meet demand. These issues have resulted in knock-on supply disruptions of alternative PERT medications.The Department is continuing to work with all suppliers of PERT to help resolve the supply issues in the short and longer term by asking that they expedite deliveries, source stock from other markets, and increase production. The Department has also reached out to specialist importers of unlicensed medicine to understand whether they can source unlicensed imports of Creon to help mitigate this supply issue. Where such imports have been sourced, the Department has worked with the Medicines and Healthcare products Regulatory Agency to expedite regulatory processes.There are no plans to make an assessment of the potential merits of establishing a British supplier of Creon. However, we have established incentives to encourage United Kingdom life sciences manufacture, including via the Life Science Innovative Manufacturing Fund. The Government has committed up to £520 million to support businesses investing in life science manufacturing projects in the UK, and this would be open to applicants interested in setting up PERT manufacture in the UK.
16 Dec 2024·Department for Work and Pensions·Answered
AskedWhat assessment she has made of the potential merits of providing indexation of pension rights accrued before April 1997.
ReplyIt is for sponsoring employers to decide what pension benefits they offer, provided these meet minimum standards. These benefits are set out in the scheme rules. It would not be appropriate for the Government to interfere in decisions made by individual schemes, beyond setting clear, affordable minimum standards that apply to all.Pensions legislation does not usually apply new provisions retrospectively to rights that have already been accrued. It is generally seen to be unreasonable to add liabilities to pension schemes that could not have been taken into account in the funding assumptions that determined the contributions to be paid at the time. In some cases, the additional, unplanned liabilities could result in significant additional contributions from the sponsoring employer, and could ultimately threaten the future viability of some schemes.It is important to achieve a balance between providing members with some measure of protection against inflation and not increasing schemes’ costs beyond a level that schemes and employers can generally afford.
16 Dec 2024·Ministry of Housing, Communities and Local Government·Answered
AskedCommunities and Local Government, with reference to page 101 of the English Devolution White Paper, published on 16 December 2024, whether she plans to postpone local authority elections in Kent in 2025.
ReplyI will consider any requests I receive to postpone the May 2025 local authority elections in Kent and Warwickshire only where this will help the areas to deliver both reorganisation and devolution to the most ambitious timeframe – either through the Devolution Priority Programme or where reorganisation is necessary to unlock devolution or open up new devolution options. As I set out in my letter of 16 December to those councils, I will need a clear commitment to these aims, including a request from the council(s) whose election is to be postponed, on or before Friday 10 January.
16 Dec 2024·Department of Health and Social Care·Answered
AskedIf he will make an assessment of the potential merits of establishing a Medicines Shortages Task Force.
ReplyWhile there are no plans to establish a Medicines Shortages Task Force, there is a team within the Department that deals specifically with medicine supply problems. They work closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, and others operating in the supply chain to help prevent shortages and to ensure that the risks to patients are minimised when shortages do arise.The resilience of United Kingdom’s supply chains is a key priority, and we are continually learning and seeking to improve the way we work to both manage and help prevent supply issues, and avoid shortages for patients. The Department, working closely with NHS England, is taking forward a range of actions to improve our ability to mitigate and manage shortages and strengthen our resilience. However, medicine shortages are a complex and global issue and everyone in the supply chain has a role to play in addressing them, as any action will require a collaborative approach.There are approximately 14,000 medicines licensed for supply in the UK, and while most are in good supply, there can sometimes be supply issues with a limited number of medicines. Supply disruption is an issue which affects the UK, as well as the other countries around the world. High-profile medicine supply issues have been global in their nature.
16 Dec 2024·Department of Health and Social Care·Answered
AskedWhat assessment he has made of the impact of supply chain issues surrounding the importing of Creon into the United Kingdom on patients with pancreatic diseases; and what steps he is taking to increase the amount of Creon being imported into the United Kingdom.
ReplyThe Department has been working with suppliers to address the current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy (PERT) used by patients with conditions such as cystic fibrosis and certain cancers, including pancreatic cancer. The supply issues with Creon are impacting countries throughout Europe and have been caused by the limited availability of raw ingredients and manufacturing capacity constraints to produce volumes needed to meet demand. These issues have resulted in knock-on supply disruptions of alternative PERT medications.The Department is continuing to work with all suppliers of PERT to help resolve the supply issues in the short and longer term by asking that they expedite deliveries, source stock from other markets, and increase production. The Department has also reached out to specialist importers of unlicensed medicine to understand whether they can source unlicensed imports of Creon to help mitigate this supply issue. Where such imports have been sourced, the Department has worked with the Medicines and Healthcare products Regulatory Agency to expedite regulatory processes.
16 Dec 2024·Home Office·Answered
AskedPursuant to the Answer of 29 November 2024 to Question 16106 on Overseas Students: Ukraine, whether students who have extended visas under the Ukraine Permission Extension scheme and whose graduation date falls after the expiration of that visa will (a) be allowed to remain to complete their studies and (b) retain home fee status for the duration of their course.
ReplyThose granted permission under the Ukraine Permission Extension scheme will receive the same rights and entitlements to access work, benefits, healthcare and education as provided under the existing Ukraine Schemes.Individuals with permission under one of the Ukraine schemes will have access to standard immigration routes to remain in the UK, in order to complete higher education courses they commence during their initial period of permission.Where a person's Ukraine scheme permission expires during their course of study and they are granted further permission to remain under one of the standard immigration routes, they will continue to be eligible to access student support and home fee status while they complete their studies.
16 Dec 2024·Foreign, Commonwealth and Development Office·Answered
AskedCommonwealth and Development Affairs, what steps his Department has taken to raise the UN Working Group on Arbitrary Detention's ruling that the United Arab Emirates has unlawfully detained Ryan Cornelius with the government of that country.
ReplyThe FCDO takes the opinions of the UN Working Group on Arbitrary Detention seriously. We continue to provide consular assistance to Mr Cornelius and his case has been raised at senior levels, highlighting the Government's support for his appeal for clemency.